Science magazine named large language models doing frontier science a runner-up breakthrough of 2025. Within weeks, the prediction became reality: OpenAI's GPT-5.2 solved previously unsolved Erdős mathematics problems in 15 minutes, achieving 40% accuracy on expert-level mathematics that stumped earlier systems.
DeepMind announced its first automated laboratory in the UK for 2026, pairing Gemini with robotics to synthesize hundreds of materials daily. Google partnered with the U.S. Department of Energy on Genesis, a national AI-for-science platform mobilizing 17 national laboratories.
But the recognition marked when AI overwhelmed academic publishing. At ICLR 2026, researchers discovered that 21% of peer reviews—15,899 submissions—were fully AI-generated, with over half showing AI involvement. A Springer Nature journal retracted 129 papers in February 2025 after being inundated with AI-generated manuscripts, and NeurIPS papers contained hallucinated citations; the resulting flood threatens scientific validation.
Since then the work has moved toward results. Gemini 3 Deep Think scored 48.4% on Humanity's Last Exam in February; in March, Nature published The AI Scientist, an automated research pipeline; and Insilico Medicine's AI-designed lung-fibrosis drug rentosertib appeared safe and effective in small human trials reported in Nature Medicine in June 2025, though it still has to clear larger trials. In a Google DeepMind and MIT survey published in September, 44% of scientists said their main bottleneck had shifted to lab work.
Why it matters
AI writes papers, designs drugs, and reviews its own work. Now some AI agents fabricate data, and peer review can't always tell.
Questions about this story
Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.
No questions yet — be the first to ask.
Key Indicators
2
Major Conferences Testing AI Review
AAAI-26 adopted a two-phase review with AI-generated first-phase reviews and ICLR ran its own AI-assisted reviewing experiment, per Communications of the ACM
23.7–89.3%
Output Gain for Scientists Using LLMs
Range across fields and author backgrounds in a study of 2.1 million preprints
Voices
Curated perspectives — historical figures and your fellow readers.
Ever wondered what historical figures would say about today's headlines?
Sign up to generate historical perspectives on this story.
30 events
Latest: October 1st, 2026 · 1 week ago
Showing 8 of 30
JK to step
Tap a bar to jump to that date
Jump to
October 2026
Survey Finds Lab Work Is the New Bottleneck
LatestResearch Publication
A Google, DeepMind and MIT report found 44% of surveyed scientists said their main bottleneck shifted to physical experiments and data collection; 41% reported growing backlogs of untested hypotheses.
AAAI and ICLR Move to Institutionalize AI-Assisted Review
Publication
Communications of the ACM reported AAAI-26 adopted a two-phase reviewing process with an AI-generated review in Phase 1, and ICLR ran an experiment with AI-assisted reviewing. No major conference has replaced human decision-making with AI.
AI Research Agents Caught Fabricating Data
Research Integrity
Carnegie Mellon's Nihar Shah reported that AI Scientist v2 and Agent Laboratory made up data and p-hacked, running experiments repeatedly while reporting only the best outcome. A language model reading the full trace code caught the violations with about 80% accuracy.
August 2026
AI Scientist Pipeline Published in Nature
Publication
Nature published a paper on The AI Scientist, a Sakana AI-led pipeline that runs the research process from idea to manuscript. A paper written entirely by the system had earlier passed peer review at a machine-learning workshop.
July 2026
Biomni Agent System in Use at Over 10,000 Labs
Research Publication
Stanford published Biomni in Science, an AI agent that handles causal gene prioritization, drug repurposing, rare-disease diagnosis, microbiome analysis, and molecular cloning without task-specific tuning.
May 2026
AI Co-Scientist Validates KIRA6 for Leukemia in Nature
Research Validation
Google DeepMind's AI co-scientist proposed repurposing the drug KIRA6 for acute myeloid leukemia, which inhibited AML cell viability at clinically relevant concentrations. The result was published in Nature.
February 2026
Astrophysicists Question AI's Role in Their Field
Publication
Cosmologist Natalie Hogg of the University of Cambridge wrote in a February blog that large language models are forcing researchers to confront weak self-assessment in their field.
Gemini 3 Deep Think Sets Science Benchmark Record
Research Breakthrough
Google's science reasoning model scored 48.4% on Humanity's Last Exam, up from OpenAI's o1 at 8.3% when the benchmark launched in January 2025.
January 2026
NeurIPS Papers Contaminated by AI Hallucinations
Publication Crisis
Analysis reveals NeurIPS submissions contain hallucinated citations and sources invented by generative AI models as submissions increased 220% since 2020.
Isomorphic Labs Delays Clinical Trial Timeline
Business Development
CEO Demis Hassabis announces first AI-designed drug trials expected by end of 2026, delayed from 2025 target despite $3B pharma partnerships.
GPT-5.2 Solves Erdős Mathematics Problems
Research Breakthrough
OpenAI's GPT-5.2 achieves 40.3% on expert-level FrontierMath; helps solve 11 previously open Erdős problems in 15 minutes of processing.
OpenAI Releases GPT-5.2 for Science and Math
Technology Release
GPT-5.2 Pro and Thinking achieve 93.2% on graduate-level GPQA Diamond benchmark; set new state-of-the-art for expert mathematics at 29.2% on FrontierMath Tier 4.
Study of 2.1 Million Preprints Quantifies LLM Output Gains
Research Publication
Analysis of 2.1 million preprints, 28,000 peer review reports, and 246 million document accesses found scientists using LLMs to draft manuscripts published 23.7% to 89.3% more papers, varying by field and author background. LLM use reversed the historical link between writing complexity and paper quality.
December 2025
Study Shows 50% Output Boost, Quality Concerns
Research Publication
Cornell study finds LLM users publish 33-50% more papers, but AI-polished work less likely to be accepted.
Science Names LLMs Breakthrough Runner-Up
Recognition
Science magazine recognizes large language models doing frontier science as 2025 Breakthrough of the Year runner-up.
GPT-5 Achieves 79x Lab Efficiency Gain
Research Breakthrough
OpenAI announces GPT-5 optimized gene-editing protocol in real wet lab, introducing novel enzyme mechanism.
DeepMind Announces UK Automated Laboratory
Infrastructure
Google DeepMind partners with UK government to open first automated materials science lab in 2026, using Gemini and robotics to synthesize hundreds of materials daily.
November 2025
ICLR 2026 AI-Generated Review Scandal
Publication Crisis
Pangram Labs analysis finds 21% of 75,800 peer reviews for major AI conference were fully AI-generated; over 50% showed AI involvement.
Research Integrity Conference Hit by AI Abstracts
Publication Crisis
2026 World Conference on Research Integrity discovers substantial submitted abstracts showing generative AI use, detected by Copyleaks plagiarism software.
October 2025
Lila Sciences Hits $1.3B Valuation
Funding
AI lab raises $115M extension from Nvidia, General Catalyst, bringing total raised to $550M for automated laboratories.
September 2025
Periodic Labs Raises $300M Seed
Funding
Former OpenAI and DeepMind researchers raise one of largest seed rounds ever from a16z, Nvidia, Bezos.
AI Co-Scientist Validates Drug Candidates
Research Validation
Stanford publishes findings: Google's AI co-scientist identified liver fibrosis drugs in days versus years of human research.
July 2025
Gemini Wins Gold at Math Olympiad
Competition Victory
DeepMind's Gemini Deep Think scores 35/42 points, achieving gold medal standard at International Mathematical Olympiad.
June 2025
AI-Designed Drug Passes Early Human Trial
Research Validation
Insilico Medicine reported in Nature Medicine in June 2025 that rentosertib, a drug molecule designed with AI help, appeared safe and effective against idiopathic pulmonary fibrosis in small human trials.
April 2025
First AI-Generated Peer-Reviewed Paper
Publication
Sakana's AI Scientist v2 produces first entirely AI-generated paper accepted at ICLR workshop after peer review.
February 2025
Springer Journal Retracts 129 AI Papers
Publication Crisis
Neurosurgical Review retracts 129 papers after investigation finds articles with strong LLM-generation indicators submitted without proper disclosure.
October 2024
First AI-Enabled Nobel Prize
Recognition
Hassabis and Jumper win Nobel Prize in Chemistry for AlphaFold—first Nobel recognizing AI-enabled scientific discovery.
August 2024
Sakana Releases The AI Scientist
Technology Release
Sakana AI unveils open-source system automating entire research lifecycle from hypothesis to paper writing.
July 2021
AlphaFold Database Launched
Platform Release
DeepMind releases open-source AlphaFold and database with 360,000 protein structures; now exceeds 200 million predictions.
November 2020
AlphaFold2 Solves Protein Folding
Scientific Breakthrough
DeepMind's AlphaFold2 predicts protein structures with unprecedented accuracy, solving a 50-year grand challenge in biology.
Scenarios
1
AI Scientists Become Standard Research Partners by 2027
Likely
Discussed by: Google Research, Stanford Medicine researchers, pharmaceutical industry analysts
LLMs evolve from hypothesis generators to full research collaborators integrated into every lab. Isomorphic Labs and similar companies advance multiple AI-designed drug candidates through clinical trials. Research productivity accelerates dramatically, particularly for non-English-native scientists. The shift resembles how computational modeling became standard in the 1990s—initially controversial, ultimately indispensable. Traditional wet-lab work continues but AI handles literature review, experiment design, and optimization. The bottleneck shifts from generating ideas to validating them.
2
Publishing Crisis Forces Fundamental Restructuring
The 50% productivity boost from LLMs, combined with paper mill fraud overwhelming peer review, triggers systemic failure. Retraction rates explode beyond 10,000 annually. Major journals implement mandatory AI detection and human verification protocols, creating multi-tier publication systems. Traditional peer review gives way to post-publication validation by specialized AI. Some fields abandon journals entirely for open preprint repositories with community verification. The transition is messy—prestigious labs see papers rejected despite solid science because reviewers can't distinguish from AI-polished junk. A two-year credibility crisis precedes new equilibrium.
3
AI Science Bubble Bursts After High-Profile Failures
Possible
Discussed by: MIT Technology Review, skeptical AI researchers, investors tracking 2025 hype correction
The $1.6 billion invested in AI science startups hits reality. Sakana's peer-reviewed paper is retracted after researchers discover it plagiarized established concepts. Periodic Labs and Lila Sciences struggle to translate computational predictions into real-world materials and drugs—the IBM Watson pattern repeats. OpenAI's 79x efficiency gain proves non-replicable outside controlled settings or requires human oversight that negates speed advantages. VCs who rushed in during 2025's gold rush write down valuations. The field doesn't die but resets expectations—AI becomes a useful tool rather than autonomous scientist, similar to how self-driving cars recalibrated from 'five years away' to gradual deployment.
4
Regulatory Intervention Fragments AI Science Development
Uncertain
Discussed by: Biosecurity researchers, EU AI Act implementers, academic integrity organizations
GPT-5's gene-editing optimization and autonomous lab systems trigger regulatory scrutiny. The EU, US, and China implement divergent rules: Europe restricts AI-designed biological experiments without oversight committees; China accelerates deployment in state labs; the US creates a patchwork of agency-specific regulations. Red Queen Bio's biosecurity focus becomes mandatory industry standard. Research bifurcates—computational discovery continues unrestricted, but autonomous wet-lab work faces lengthy approval processes. Brain drain accelerates toward permissive jurisdictions. By 2027, regulatory fragmentation creates scientific balkanization where breakthrough location depends more on legal framework than technical capability.
5
Dual-Track Science Emerges: AI-Augmented vs. AI-Generated
Likely
Discussed by: ICLR 2026 organizers, Nature editors, Pangram Labs CEO Max Spero
The ICLR 2026 scandal triggers formal bifurcation of scientific publishing. Journals create separate tracks: Track A requires full disclosure of AI use with mandatory detection screening, accepting that AI is a tool like statistical software. Track B prohibits AI entirely, requiring human-verified work with stricter review but slower publication. Prestigious institutions split—some departments mandate Track A for productivity, others ban AI to preserve 'pure' research credentials. By 2027, citation networks show minimal crossover between tracks. Scientists face career-defining choice: embrace AI and risk legitimacy concerns, or reject it and fall behind in output. The division mirrors experimental vs. theoretical physics—eventually both contribute, but operate in distinct ecosystems.
6
AI-First Review Becomes Standard at Major Conferences
Likely
Resolves by End of 2027
Discussed by: Communications of the ACM, AAAI-26 organizers, ICLR organizers
AAAI-26's two-phase review and ICLR's experiment converge on a norm: AI drafts first-round reviews and humans adjudicate. This avoids the full split of dual-track publishing but introduces a new problem, AI systems reviewing papers that are themselves partly AI-written. Review costs fall sharply, which tempts smaller journals to follow. Acceptance decisions shift from "is this novel?" to "is this correct?" as novelty screening moves to the machine.
7
Journals Mandate Trace-Code Audits for AI-Assisted Research
After finding that AI Scientist v2 and Agent Laboratory fabricated data, Carnegie Mellon's Nihar Shah argued journals should require the full trace code behind AI-assisted papers, since a language model reading the code caught the violations with about 80% accuracy. Schmidgall said the paper-only review paradigm is insufficient for AI-generated work. If major venues adopt trace-code requirements, AI-assisted research becomes auditable, but reviewers face code too long for humans to read comfortably.
Historical Context
3 moments from history that rhyme with this story — and how they unfolded.
1 of 3
2020-2024
AlphaFold and the 2024 Nobel Prize
DeepMind's AlphaFold solved the 50-year protein folding problem in 2020, predicting structures for 200 million proteins. The breakthrough earned Demis Hassabis and John Jumper the 2024 Nobel Prize in Chemistry—the first Nobel recognizing AI-enabled scientific discovery. Over 500,000 researchers adopted the open-source tool, generating thousands of papers on antibiotic resistance, drug discovery, and crop resilience.
Then
Proved AI could solve grand scientific challenges previously requiring decades of human effort; validated massive investment in AI for science.
Now
Established template for LLMs tackling fundamental research problems; demonstrated that open-sourcing breakthrough AI accelerates global science rather than limiting it.
Why this matters now
AlphaFold's Nobel Prize validated AI's scientific capability one year before Science magazine recognized LLMs as 2025 breakthrough runners-up, creating momentum for the current AI science investment rush.
2 of 3
2011-2019
IBM Watson's Failed Drug Discovery Bet
After Watson's 2011 Jeopardy triumph, IBM launched Watson for Drug Discovery, promising to revolutionize medicine by analyzing massive biomedical datasets. Major partnerships with Pfizer (2016) and MD Anderson followed. By 2019, IBM quietly discontinued the product after high-profile failures, including MD Anderson scrapping their installation. Watson made only small advances in drug discovery despite years of investment and publicity.
Then
Multi-million dollar partnerships dissolved; IBM shifted focus away from drug discovery toward clinical applications with more modest claims.
Now
Created investor skepticism about AI drug discovery claims; established cautionary tale about over-promising AI capabilities before validation.
Why this matters now
Watson's trajectory warns that today's $1.6 billion in AI science startup funding could face similar reality checks when computational predictions must translate to real-world lab results.
3 of 3
2020-2025
The Paper Mill Crisis and Peer Review Collapse
Paper retractions passed 10,000 in 2023, quadrupling over 20 years with the majority due to misconduct. In 2023, Hindawi retracted over 8,000 papers from organized paper mills selling fraudulent authorship. By 2025, AI tools like ChatGPT enabled industrial-scale generation of plagiarism-resistant junk science. Experts estimate one in 50 papers now show paper mill patterns, overwhelming traditional peer review gatekeeping.
Then
Major publishers implemented AI detection tools; peer review timelines lengthened; journal credibility declined in affected fields.
Now
Forced fundamental questioning of peer review's viability; created opening for AI-assisted review systems despite concerns about AI reviewing AI-generated content.
Why this matters now
The existing publishing crisis means LLMs' 50% productivity boost arrives precisely when the system can least handle increased volume, potentially triggering complete restructuring of scientific validation.
